Regulatory Precision from Austin, TX

Accelerating Regulatory Success from Austin to the World.

Strategic guidance for pharmaceutical innovation. Navigating FDA & Global compliance with the agility of tech and the rigor of science.

Regulatory Pulse
FDA Updates Guidance on Decentralized Clinical TrialsEMA Launches New Clinical Trials Information System (CTIS) PortalICH E6(R3) Draft Guideline Released for Public ConsultationFDA Issues New Draft Guidance on AI/ML in Drug DevelopmentPMDA Updates Consultation Procedures for Regenerative MedicineFDA Updates Guidance on Decentralized Clinical TrialsEMA Launches New Clinical Trials Information System (CTIS) PortalICH E6(R3) Draft Guideline Released for Public ConsultationFDA Issues New Draft Guidance on AI/ML in Drug DevelopmentPMDA Updates Consultation Procedures for Regenerative Medicine

Excellence That Speaks for Itself

Proven track record of regulatory success across therapeutic areas and global markets.

Proven
FDA Submission Success Rate

Every submission accepted on first review

50+
Years Combined Experience

Senior regulatory leadership at top pharma

35+
Successful INDs Filed

Across multiple therapeutic areas

Multiple
NDA/BLA/NDS/MAA Approvals

Comprehensive regulatory pathway expertise

#9,186,363
US Patent Holder

Patented innovation for AMD treatment methodology

Therapeutic Areas of Expertise

👁️
Ophthalmology
🧠
Neurology
🦠
Infectious Disease
💊
Rare Diseases
🔬
Medical Devices

The Path to Approval

Navigating the product lifecycle with precision.

01
🧭

Strategic Feasibility

Early-stage gap analysis and regulatory pathway definition to de-risk development.

02
📄

Submission Readiness

Authoring and compiling IND/CTA, NDA/BLA, and MAA submissions with full eCTD compliance.

03
🤝

Agency Liaison

Direct representation and negotiation with FDA, EMA, and global health authorities.

04
🧬

Lifecycle Management

Post-market variations, labeling updates, and CMC change controls.

Comprehensive Services

End-to-end regulatory support from discovery to post-market lifecycle management.

Regulatory Strategy

  • Target Product Profile Development
  • Regulatory Pathway Selection
  • Pre-IND/CTA Meeting Preparation
Learn More

CMC & Quality Compliance

  • Module 3 Authorship & Review
  • GMP Compliance Audits
  • 21 CFR Part 11 Document Management
Learn More

FDA Submissions

  • IND/NDA/BLA Authoring
  • eCTD Publishing & Validation
  • 505(b)(2) Applications
Learn More

Global Submissions

  • EMA MAA Preparation
  • Health Canada Submissions
  • PMDA Consultations
Learn More

Lifecycle Management

  • Post-Market Variations
  • Annual Reports
  • Labeling Updates
Learn More

Due Diligence

  • Regulatory Gap Analysis
  • M&A Support
  • Portfolio Assessment
Learn More
Peter Parsonson, Founder & Principal Consultant
20+
Years Experience
100%
Success Rate
The Adelphi Difference

Led by Proven Expertise

Founded by experienced regulatory affairs professionals with over 50 years of combined experience navigating the complex landscape of pharmaceutical approvals.

Our team has achieved multiple NDA, BLA, NDS, and MAA approvals across therapeutic areas including orphan drugs, ophthalmology, infectious disease, and wound care—a testament to our ability to shepherd breakthrough therapies through the most rigorous regulatory pathways.

Strategic Vision
From IND to approval
Global Reach
FDA, EMA, PMDA expertise
Trusted Partner
Biotech to Big Pharma
Proven Results
100% submission success
The Austin Advantage

Agility Meets Compliance

Headquartered in Austin, Texas—a hub of biotechnology and innovation. We bring the agility of the tech sector to the rigor of pharmaceutical compliance.

While others are stuck in traditional consulting models, we leverage modern tools and adaptive strategies to keep your regulatory timeline moving forward.

Learn About Our Approach
Start Your FDA Journey

Ready to Navigate Your Path to FDA Approval?

Let's discuss how Adelphi Biosciences can help accelerate your regulatory strategy. Schedule a free consultation with Peter Parsonson to explore your unique needs.

  • Free 30-minute strategic consultation
  • Same-day response guarantee
  • No obligation assessment
  • Confidential discussion
✉️

Let's Connect

We respond within 24 hours

📧
Email
Peter.Parsonson@adelphibiosciences.com
💼
LinkedIn
Connect with Peter Parsonson
Proven Success Rate ⭐
FDA submissions across career